Sinopharm's two vaccines have over 70% efficacy in Phase III trials
CGTN, 27 May 2021
For more:
https://news.cgtn.com/news/2021-05-27/Sinopharm-s-two-vaccines-have-over-70-efficacy-in-Phase-III-trials-10BtoxirXCU/index.html
Chinese #vaccine manufacturer #Sinopharm claims two of its COVID-19 vaccines have over 70 percent efficacy based on Phase Three clinical trials on inactivated vaccines. According to the first detailed results of a large late-stage study published in the Journal of the American Medical Association on Wednesday, the two inactivated vaccines demonstrated efficacies of 72.8 percent and 78.1 percent. #Coronavirus
Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
https://news.cgtn.com/news/2021-05-27/Sinopharm-s-two-vaccines-have-over-70-efficacy-in-Phase-III-trials-10BtoxirXCU/index.html
Chinese #vaccine manufacturer #Sinopharm claims two of its COVID-19 vaccines have over 70 percent efficacy based on Phase Three clinical trials on inactivated vaccines. According to the first detailed results of a large late-stage study published in the Journal of the American Medical Association on Wednesday, the two inactivated vaccines demonstrated efficacies of 72.8 percent and 78.1 percent. #Coronavirus
Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
